Effects of Chinese herbal medicine in patients with benign prostatic hyperplasia: A nationwide cohort study in Taiwan

被引:1
|
作者
Ou, Shi-Chen [1 ,2 ]
Huang, Sheng-Teng [1 ,3 ,4 ,5 ]
Lin, Mei-Chen [6 ]
Chen, Wen-Chi [7 ,8 ]
Huang, Chi-Ping [7 ,9 ]
Lin, Hung-Jen [1 ,2 ]
机构
[1] China Med Univ Hosp, Dept Chinese Med, 2 Yude Rd, Taichung 404, Taiwan
[2] China Med Univ, Sch Post Baccalaureate Chinese Med, Taichung, Taiwan
[3] China Med Univ, Sch Chinese Med, Taichung, Taiwan
[4] China Med Univ Hosp, Canc Res Ctr Tradit Chinese Med, Dept Med Res, Taichung, Taiwan
[5] China Med Univ, Nan Hosp, Tainan, Taiwan
[6] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan
[7] China Med Univ Hosp, Dept Urol, Taichung, Taiwan
[8] China Med Univ, Grad Inst Integrated Med, Taichung, Taiwan
[9] China Med Univ, Sch Med, Taichung, Taiwan
关键词
benign prostatic hyperplasia; Chinese herbal medicine; Ji-Sheng-Shen-Qi-Wan; National Health Insurance Research Database; retrospective cohort study; URINARY-TRACT SYMPTOMS; DOUBLE-BLIND; MEN; DUTASTERIDE; FINASTERIDE; GUIDELINES;
D O I
10.1111/iju.14853
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives Benign prostatic hyperplasia affects elderly males, with progression presenting the risk of urinary complications and eventual surgical intervention. We aimed to evaluate the effects of Chinese herbal medicine in patients with benign prostatic hyperplasia. Methods This retrospective cohort study analyzed claims data in Taiwan's National Health Insurance Research Database from 2001 to 2013. A total of 4142 patients newly diagnosed as benign prostatic hyperplasia were enrolled and divided into cohorts of Chinese herbal medicine users and nonusers by performing 1:1 propensity score matching. The risk of benign prostatic hyperplasia-related complications was assessed by the Cox proportional hazard model. The cumulative incidence of benign prostatic hyperplasia-related surgeries was assessed by Kaplan-Meier method. Results During the study period, the risk of benign prostatic hyperplasia-related complications was lower in the Chinese herbal medicine cohort than non-Chinese herbal medicine cohort with an adjusted hazard ratio of 0.82 (95% confidence interval 0.73-0.92) after controlling for multiple variables. Subgroup analysis revealed that Chinese herbal medicine users had a significantly lower risk of urinary tract infection (adjusted hazard ratio 0.67, 95% confidence interval 0.50-0.89) and urinary retention (adjusted hazard ratio 0.83, 95% confidence interval 0.72-0.97). In addition, Chinese herbal medicine users also had a lower incidence rate of benign prostatic hyperplasia-related surgery (32.14 vs 40.20, adjusted hazard ratio 0.74, 95% confidence interval 0.61-0.89) and a longer surgery-free interval than non-Chinese herbal medicine users (3.98 vs 3.00 mean person-year, P < 0.001). Data revealed Salviae miltiorrhizae and Ji-Sheng-Shen-Qi-Wan as the most commonly prescribed Chinese herbal medicine by traditional Chinese medicine practitioners. Conclusions Our study demonstrated that Chinese herbal medicine might have effects in the benign prostatic hyperplasia-related complications and surgeries in patients with benign prostatic hyperplasia.
引用
收藏
页码:623 / 630
页数:8
相关论文
共 50 条
  • [41] Chinese herbal medicine may reduce major adverse cardiovascular events in patients with dialysis hypotension: A Taiwan nationwide cohort study (vol 14, pg 550, 2024)
    Tsai, Ming-Yen
    Huang, Po-Yu
    Lee, Wen-Chin
    Cheng, Ben-Chung
    Tsai, Fuu-Jen
    Liu, Chun-Ting
    JOURNAL OF TRADITIONAL AND COMPLEMENTARY MEDICINE, 2025, 15 (01): : 105 - 105
  • [42] Chronic Periodontitis as a Risk Factor for Benign Prostatic Hyperplasia: A Cohort Study
    Kwon, Mi Jung
    Kang, Ho Suk
    Choi, Hyo Geun
    Kim, Joo Hee
    Yoo, Dae Myoung
    Lee, Na Eun
    Han, Kyeong Min
    Bang, Woo Jin
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (04)
  • [43] Drug utilization pattern among patients with benign prostatic hyperplasia in Korea: A large cohort study
    Jeon, Nakyung
    Yang, Minjune
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 530 - 530
  • [44] The correlation between obesity and prostate volume in patients with benign prostatic hyperplasia: A prospective cohort study
    Negi, Saurabh Kumar
    Desai, Sandip
    Faujdar, Gaurav
    Jaiswal, Sanjeev
    Sahu, Ram Dayal
    Vyas, Nachiket
    Priyadarshi, Shivam
    UROLOGIA JOURNAL, 2024, 91 (03) : 512 - 517
  • [45] Association between chronic obstructive pulmonary disease and increased risk of benign prostatic hyperplasia: a retrospective nationwide cohort study
    Peng, Yi-Hao
    Huang, Chien-Wen
    Liao, Wei-Chih
    Chen, Hsuan-Ju
    Yin, Ming-Chien
    Huang, Yu-Ming
    Wu, Trong-Neng
    Ho, Wen-Chao
    BMJ OPEN, 2017, 7 (06):
  • [46] The clinical effects of amitriptyline on nocturia in patients with benign prostatic hyperplasia
    Jeong, H. J.
    Han, D. Y.
    Oh, S. J.
    Park, S. C.
    Rim, J. S.
    Roh, J. H.
    Kim, J. S.
    EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (03) : 170 - 170
  • [47] Suicidal risk associated with finasteride versus dutasteride among men treated for benign prostatic hyperplasia: nationwide cohort study
    Laanani, Moussa
    Weill, Alain
    Jollant, Fabrice
    Zureik, Mahmoud
    Dray-Spira, Rosemary
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [48] Re: The Preventive Effect of Metformin on Progression of Benign Prostatic Hyperplasia: A Nationwide Population-Based Cohort Study in Korea
    Kaplan, Steven A.
    JOURNAL OF UROLOGY, 2020, 204 (06): : 1354 - 1355
  • [49] Suicidal risk associated with finasteride versus dutasteride among men treated for benign prostatic hyperplasia: nationwide cohort study
    Moussa Laanani
    Alain Weill
    Fabrice Jollant
    Mahmoud Zureik
    Rosemary Dray-Spira
    Scientific Reports, 13
  • [50] Changes in diagnosis rate and treatment trends of benign prostatic hyperplasia in Korea: A nationwide population-based cohort study
    Kim, Do Kyung
    Park, Jae Joon
    Yang, Won Jae
    Doo, Seung Whan
    Kim, Jae Heon
    Song, Yun Seob
    PROSTATE INTERNATIONAL, 2021, 9 (04) : 215 - 220